Evidence map›Paper›PMID 40204507›Full record

ArticleAllergy, asthma & immunology research2025

Analysis of miRNA Expression in Patients With NSAID-Exacerbated Respiratory Disease.

Adrian Gajewski, Adrian Bekier, Karolina Frachowicz-Guereirro, Izabela Drożdż, Rafał Ćwikliński, Marcin Kurowski, Marek L Kowalski, Ralf Baumann, Carsten Schmidt-Weber, Adam M Chaker and 2 more

Abstract read
In one paragraph

Article in Allergy, asthma & immunology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Distinct miRNA expression patterns in circulating eosinophil subtypes and their subtype-derived exosomes in allergic asthma.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Adrian GajewskiDepartment of Immunology and Allergy, Medical University of Lodz, Lodz, Poland.ORCID https://orcid.org/0000-0001-7445-9752
Adrian BekierDepartment of Immunology and Allergy, Medical University of Lodz, Lodz, Poland.ORCID https://orcid.org/0000-0002-4980-1074
Karolina Frachowicz-GuereirroDepartment of Immunology and Allergy, Medical University of Lodz, Lodz, Poland.ORCID https://orcid.org/0000-0003-4599-1445
Izabela DrożdżDepartment of Clinical Genetics, Medical University of Lodz, Lodz, Poland.ORCID https://orcid.org/0000-0003-1956-5063
Rafał ĆwiklińskiDepartment of Immunology and Allergy, Medical University of Lodz, Lodz, Poland.
Marcin KurowskiDepartment of Immunology and Allergy, Medical University of Lodz, Lodz, Poland.ORCID https://orcid.org/0000-0002-0653-7533
Marek L KowalskiDepartment of Immunology and Allergy, Medical University of Lodz, Lodz, Poland.ORCID https://orcid.org/0000-0002-8442-2774
Ralf BaumannInstitute for Occupational, Social and Environmental Medicine, Medical Faculty, University Hospital RWTH Aachen University, Aachen, Germany.ORCID https://orcid.org/0000-0002-6523-1024
Carsten Schmidt-WeberCenter of Allergy and Environment (ZAUM), Technical University and Helmholtz Center Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.ORCID https://orcid.org/0000-0002-3203-8084
Adam M ChakerCenter of Allergy and Environment (ZAUM), Technical University and Helmholtz Center Munich, Member of the German Center for Lung Research (DZL), Munich, Germany.ORCID https://orcid.org/0000-0002-5117-4073
Maciej ChałubińskiDepartment of Immunology and Allergy, Medical University of Lodz, Lodz, Poland.ORCID https://orcid.org/0000-0001-8311-9530
Aleksandra WardzyńskaDepartment of Immunology and Allergy, Medical University of Lodz, Lodz, Poland. aleksandra.wardzynska@umed.lodz.pl.ORCID https://orcid.org/0000-0001-6253-2799

Funding

EIT Health 19065
6 · The paper itself

Abstract

purposeNon-steroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD) is a phenotype of bronchial asthma that is characterized by a severe course and the presence of chronic rhinosinusitis (CRS) with nasal polyps. MicroRNAs (miRNAs) belong to a family of small, non-coding RNAs whose primary function is to regulate gene transcription. The aim of this study was to determine the miRNA profile and to validate selected miRNAs in biological material from the upper respiratory tract collected with a minimally-invasive method in patients with N-ERD.

methodsThe miRNA profile was assessed in subjects with N-ERD, CRS, and allergic asthma (AA), as well as healthy controls (HCs), using microarray technique. Following this, 6 miRNAs were validated using reverse transcription polymerase chain reaction in 77 subjects.

resultsThe profiling identified 23 miRNAs whose expression significantly differed between patients with N-ERD and HCs. Based on these results, 6 miRNAs were selected for further validation. It was found that patients with N-ERD had significantly different expressions of miR-34a-5p and miR-22-5p compared to those with AA. In the whole study group, significant correlations were found between miR-7d-3p/miR-34a-5p/miR-22-5p and the presence of blood eosinophilia (

conclusionsThe results indicate that the miRNA profile in nasal mucosal lining fluid of patients with N-ERD differs from patients with AA, CRS, and compared to HCs. Some of the miRNAs selected on the basis of profiling may be involved in the regulation of eosinophilic inflammation in the respiratory tract. Our findings suggest that specific miRNAs may be considered as potential biomarkers of N-ERD.

Indexed as

asthmabiomarkerdrug hypersensitivityeosinophilsMicroRNAsnasal mucosa

Identifiers

PMID40204507
PMCPMC11982641

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.